TerrAscend Community

TSX:TSND Community

3 Narratives written by author
0 Comments on narratives written by author
3 Fair Values set on narratives written by author

US Cannabis Legalization And Digital Health Will Unlock Opportunities

Key Takeaways Expansion into new states, operational efficiencies, and premium branding position TerrAscend for strong revenue growth and improved margins versus industry peers. Strategic M&A, digital platform expansion, and disciplined cost control create potential for sustainable earnings growth and increased market share as the sector consolidates.Read more

CA$2.25

75.6% undervalued

AnalystHighTarget Fair Value

Revenue growth

0.96% p.a.

Profit Margin

1.2%

Future PE

223.42x

Share price in 2028

CA$3.27

TerrAscend

Expanding Adult-Use And Medical Cannabis Markets Will Redefine The Industry

Key Takeaways Expansion into newly legalized states and premium product offerings position the company for sustained revenue growth and improved profitability as markets broaden. Vertical integration, strategic M&A, and digital-first initiatives enhance cost efficiency, operating margins, and reduce risk through focus on high-growth, regulated markets.Read more

CA$1.88

70.7% undervalued

AnalystConsensusTarget Fair Value

Revenue growth

1.4% p.a.

Profit Margin

1.2%

Future PE

184.55x

Share price in 2028

CA$2.72

TerrAscend

North American Cannabis Will Face Oversupply And Risks Yet Recover

Key Takeaways Dependence on regulatory progress and geographic concentration makes growth and margins vulnerable to shifting laws, competition, and price compression in key U.S. markets. Industry oversupply, persistent stigma, and potential new competitors could limit sales momentum, erode margins, and challenge long-term earnings resilience.Read more